Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study.

Kurta ML, Moysich KB, Weissfeld JL, Youk AO, Bunker CH, Edwards RP, Modugno F, Ness RB, Diergaarde B.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1282-92. doi: 10.1158/1055-9965.EPI-12-0426.

2.

Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies.

Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, Purdie DM, Risch HA, Vergona R, Wu AH.

Am J Epidemiol. 2002 Feb 1;155(3):217-24.

PMID:
11821246
3.

Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study.

Asante A, Leonard PH, Weaver AL, Goode EL, Jensen JR, Stewart EA, Coddington CC.

Fertil Steril. 2013 Jun;99(7):2031-6. doi: 10.1016/j.fertnstert.2013.02.010.

4.

Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study.

Jensen A, Sharif H, Frederiksen K, Kjaer SK.

BMJ. 2009 Feb 5;338:b249. doi: 10.1136/bmj.b249.

5.

Risk of cancer after use of fertility drugs with in-vitro fertilisation.

Venn A, Watson L, Bruinsma F, Giles G, Healy D.

Lancet. 1999 Nov 6;354(9190):1586-90.

PMID:
10560672
6.

Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.

Merritt MA, De Pari M, Vitonis AF, Titus LJ, Cramer DW, Terry KL.

Hum Reprod. 2013 May;28(5):1406-17. doi: 10.1093/humrep/des466.

7.

Fertility drugs and risk of epithelial ovarian cancer in Italy.

Franceschi S, La Vecchia C, Negri E, Guarneri S, Montella M, Conti E, Parazzini F.

Hum Reprod. 1994 Sep;9(9):1673-5.

PMID:
7836516
8.

Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.

Bjørnholt SM, Kjaer SK, Nielsen TS, Jensen A.

Hum Reprod. 2015 Jan;30(1):222-31. doi: 10.1093/humrep/deu297.

PMID:
25376453
10.

Use of fertility drugs and risk of ovarian cancer.

Diergaarde B, Kurta ML.

Curr Opin Obstet Gynecol. 2014 Jun;26(3):125-9. doi: 10.1097/GCO.0000000000000060. Review.

11.

Induction of ovulation and ovarian cancer: a critical review of the literature.

Mahdavi A, Pejovic T, Nezhat F.

Fertil Steril. 2006 Apr;85(4):819-26. Review.

PMID:
16580355
12.

Fertility drugs and young-onset breast cancer: results from the Two Sister Study.

Fei C, Deroo LA, Sandler DP, Weinberg CR.

J Natl Cancer Inst. 2012 Jul 3;104(13):1021-7. doi: 10.1093/jnci/djs255.

13.

Infertility, fertility drugs, and invasive ovarian cancer: a case-control study.

Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN.

Fertil Steril. 1997 Jun;67(6):1005-12.

PMID:
9176436
14.

Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort.

Trabert B, Lamb EJ, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Brinton LA.

Fertil Steril. 2013 Dec;100(6):1660-6. doi: 10.1016/j.fertnstert.2013.08.008.

15.

Use of fertility drugs and risk of ovarian cancer.

Parazzini F, Pelucchi C, Negri E, Franceschi S, Talamini R, Montella M, La Vecchia C.

Hum Reprod. 2001 Jul;16(7):1372-5.

PMID:
11425815
16.

Fertility drugs and the risk of breast cancer.

Ricci E, Parazzini F, Negri E, Marsico S, La Vecchia C.

Hum Reprod. 1999 Jun;14(6):1653-5.

PMID:
10357995
17.

Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Rizzuto I, Behrens RF, Smith LA.

Cochrane Database Syst Rev. 2013 Aug 13;(8):CD008215. doi: 10.1002/14651858.CD008215.pub2. Review.

PMID:
23943232
18.

Treatment for infertility and risk of invasive epithelial ovarian cancer.

Parazzini F, Negri E, La Vecchia C, Moroni S, Franceschi S, Crosignani PG.

Hum Reprod. 1997 Oct;12(10):2159-61.

PMID:
9402274
19.

An epidemiologic case-control study of ovarian cancer and reproductive factors.

Nasca PC, Greenwald P, Chorost S, Richart R, Caputo T.

Am J Epidemiol. 1984 May;119(5):705-13.

PMID:
6539067
20.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer.

Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB.

Epidemiology. 2012 Mar;23(2):311-9. doi: 10.1097/EDE.0b013e3182456ad3.

Supplemental Content

Support Center